ethyl pyruvate has been researched along with Encephalitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, S; Li, B; Li, Z; Sun, R; Wang, J; Wang, Y | 1 |
| Chen, J; Gao, H; Gao, Y; Hu, X; Liu, C; Shen, H; Stetler, RA; Wang, S; Zhang, W | 1 |
2 other study(ies) available for ethyl pyruvate and Encephalitis
| Article | Year |
|---|---|
Improvement of hypoxia-ischemia-induced white matter injury in immature rat brain by ethyl pyruvate.
Topics: Animals; Animals, Newborn; Astrocytes; bcl-2-Associated X Protein; Brain; Caspase 3; Cerebral Ventricles; Cytokines; Encephalitis; Hypoxia-Ischemia, Brain; Neuroprotective Agents; Oligodendroglia; Proto-Oncogene Proteins c-bcl-2; Pyruvates; Rats; Rats, Sprague-Dawley | 2013 |
Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms.
Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Brain; Calcium Signaling; Calpain; Cell Death; Cytoprotection; Disease Models, Animal; Encephalitis; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Inflammation Mediators; Microglia; Nerve Degeneration; Neurons; Neuroprotective Agents; NF-kappa B; Pyruvates; Rats; Rats, Sprague-Dawley; Signal Transduction; Treatment Outcome | 2010 |